New MRI Screening Saves More Lives in Dense Breast Tissue

A breakthrough study offers hope for the 40% of women who have extremely dense breast tissue, where cancers are notoriously harder to detect on standard mammograms.

Researchers at Dartmouth's Geisel School of Medicine discovered that adding magnetic resonance imaging (MRI) to the newer 3D mammography technology saves additional lives. The study, published in Annals of Internal Medicine, simulated screening outcomes for thousands of women over their lifetimes.

The results show promise. For women with extremely dense breasts, the combined screening approach prevented an additional 0.1 to 0.8 breast cancer deaths per 1,000 women screened. While that might sound small, it translates to hundreds of lives saved across the population.

The standard 3D mammography alone already performs well, preventing 7 to 11 deaths per 1,000 average-risk women screened. For women at higher risk, that number jumps to 23 to 34 deaths averted. The supplemental MRI screening adds another layer of protection on top of those gains.

The approach works especially well for women with at least twice the average risk of breast cancer. For these women, the researchers found the screening provided good value and caught cancers that might otherwise go undetected until later stages.

There is a tradeoff. The combined screening leads to more false alarms, resulting in 22 to 186 additional biopsies that turn out not to be cancer. However, for women with moderately elevated risk, the rate of false alarms per life saved matches what average-risk women experience with standard 3D mammography alone.

The Bright Side

This research comes at a perfect time. Dense breast tissue has long frustrated doctors and worried patients because standard mammograms can miss up to half of cancers in very dense breasts. The tissue appears white on mammograms, and so do tumors, making cancers blend into the background like polar bears in snow.

Now doctors have evidence-based guidance on who benefits most from additional screening. The study shows that targeting supplemental MRI to higher-risk women with dense breasts makes medical and economic sense.

The researchers note that if MRI costs decrease and radiologists get better at reducing false positives, the screening becomes even more valuable. Both trends are already happening as technology improves and doctors gain experience.

For the millions of women who receive letters informing them they have dense breasts, this study provides a roadmap for more personalized, effective cancer screening that catches more cancers when they're most treatable.